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1. Introduction 
Inhibitors are important elements of regulation of enzyme activity. They can be named 
ubiquitous components in living organisms (Fan & Wu, 2005). There is a number of 
inhibitors, such as protein and nonprotein. Among all inhibitors, the most significant are 
inhibitors of hydrolytic enzymes. Hydrolases are enzymes that catalyze the hydrolysis of 
chemical bonds. For example, proteolytic enzymes (peptidases or proteinases) hydrolyse the 
peptide bond, glycosidic glycosidases, esterases hydrolytically cleave the ester bond (The 
Enzyme List, 2010). The inhibitors of hydrolases was found in bacteria, plants, fungi and 
animals (Rawlings et al., 2004). 
In the homeostatic state the ratio of proteinases and their inhibitors in the tissues of animals 
and humans is balanced, but at various pathological conditions, this equilibrium is 
disturbed. For example, at carcinogenesis, seeking to destroy the tissue barrier, synthesized 
mainly protease (Duffy et al., 2002). 
Changes in the ratio of activity of proteases and their inhibitors are observed in the fungal 
and bacterial skin lesions, traumatic lesions of the eye, burns, apoptosis and other 
pathological processes (Garcia-Carreno, 1996; Bohm et al., 1998; Thorburn et al., 2003; 
Wouters et al., 2008). Thus, some inhibitors are actively affected both the cellular 
environment and on the cell proteome, changing its composition (Vincent & Zivy, 2007). 
Most of them are used for medical purposes. For example, inhibitors of thrombin, a key 
factor in blood clotting. Thrombin (clotting factor II) is the trypsin-like proteases, which 
circulate in the blood in an inactive zymogen form. The search for new thrombin 
inhibitors began long before receiving the full 3D structure of thrombin. Initially, were 
synthesized short peptides containing the amino acid arginine, for example, H-Gly-Pro-
Arg-H or H-DPhe-Pro-Arg-H. Then were obtained effective non-specific serine protease 
inhibitors – ketone-derivatives of 4-amidinophenylpyruvic acid and 4-aminopyridine 
(Smith & Simons, 2004). 
One of the key enzymes of hepatitis C virus replication is a trypsin-like serine protease NS3. 
Obtained multiple protease inhibitors NS3, including macrocyclic and peptidomimetics 
(Harper et al., 2009). 
Inhibitors of hydrolytic enzymes also play an important role in plant protection. They are 
widely used use in protecting plants from fungal and bacterial diseases as well as in insect 
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control. Harvest losses associated with damage to plants by various pathogens, can reach 
100%, leading to economic disaster (Mehrabadi et al., 2010). The Republic of Kazakhstan 
is also concerned about the problem of protecting crops from pests because it is one of 
durum wheat exporter. At this reason Kazakhstan is paying attention to the study of 
inhibitors contained in wheat, barley and rice. Besides studies in agriculture sector, 
studies in medicine sector are conducted, for example in the Scientific Centre for Anti-
Infectious Drugs were developed iodine-polymer complexes as inhibitors of HIV 
integrase (Yuldasheva et al., 2011). 
2. Serine proteinase inhibitors 
Serine proteinase inhibitors long time were classified according to their characteristics, for 
example, inhibits the enzyme (trypsin inhibitors, subtilisin, etc.) or source selection - the 
chicken or ovomucoid pancreatic trypsin inhibitor or by the location of the amino acid 
residue of lysine or arginine in the reactive centre (Laskowski Jr. & Kato, 1980). This 
nomenclature is often confusing. One of the challenges ranges of inhibitors is the presence of 
several homologous domains in a single polypeptide chain (Fan & Wu, 2005; Hejgaard et al., 
2005; Dunwiddie et al., 1989). 
Typically, the inhibitors are divided by at least 10 families or types of proteinase inhibitors 
(Laskowski Jr. & Kato, 1980). Among the most studied can be noted soybeans Kunitz 
inhibitor. To the family of Kunitz inhibitors are proteins with a long polypeptide chain of 
about 170 - 200 amino acids that contain one or two disulfide bonds and a rather 
conservative N-site, and generally inhibit the activity of trypsin or chymotrypsin. One well-
studied is the soybean Kunitz inhibitor, which is a protein type globulin with a molecular 
weight of about 21.5 kDa, contains carbohydrate residues, is stable over a wide pH range 
1,0-12,0, at a temperature below 40oC. Inhibitor molecule consists of 198 amino acids at the 
N-terminal aspartic acid is located on the C-terminal leucine. Reactive centre includes the 
residue arginine-64 (Valueva & Mosolov, 2002). By the way, due to the high content of 
inhibitor in soybeans, raw soybeans, and raw foods are warming, causing the digestive 
system in mammals (Duranti M., et al. 2003). 
Inhibitors of Bowman-Birk types are widely distributed in plants and significantly different 
from the Kunitz inhibitor in their amino acid composition and are able to interact not only 
with trypsin, but with chymotrypsin (Valueva & Mosolov, 2002; Rawlings et al., 2004). 
Inhibitors of Bowman-Birk type characterized by the presence of two reactive centers on a 
single polypeptide chain rich in cysteine (7 or more residues in one polypeptide), and the 
lack of amino acid residues tryptophan and tyrosine. The molecular weight of such 
inhibitors can vary from 8 to 16 kDa. Sometimes there are inhibitors that contain two 
domains on one polypeptide chain and active only in relation to one type of enzyme 
(Valueva & Mosolov, 2002; Yan et al., 2009; Mosolov & Valueva, 2008). 
Kazal family inhibitors - the type of trypsin inhibitor-like proteinase, commonly found in 
animals, including invertebrates. Molecules consist of one or more domains, and three 
disulfide bridges. The sequence of many often conservative, but the site of binding to the 
enzyme can be variable (Li et al., 2009; Rimphanitchayakit & Tassanakajon, 2010) Kazal 
inhibitors are involved in various pathologies of the pancreas. In particular inhibitor Kazal 
SPINK1 is expressed not only in normal cells of the pancreas, but also transformed. It is 
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assumed that SPINK1 is able to stimulate proliferation of pancreatic cancer through 
epidermal growth factor receptor / proteinkinase cascade. Inhibitor SPINK1 is also 
expressed in other organs and tissues. Apparently, this indicates that the value of SPINK1 is 
not only in preventing proteolysis non-secretory of proteinases in the gut, but he also has 
some regulatory function (Ozaki et al., 2009). 
Seprpins (serin proteinase inhibitors) group of proteins, which have inhibitory activity, but 
it is not an inhibitor in the strict sense of the body and performs a different function. Among 
the most studied serpin antithrombin may be noted, ovalbumin, cortisol binding globulin, 
precursors of peptide hormones, etc. (Valueva & Mosolov, 2002; Rawlings et al., 2004). 
Serpins widespread in the proteome, and despite the name, serpins inhibit also other 
proteases, such as cysteine, aspartate etc. 
The examples of classification and nomenclature of inhibitors, really confusing and 
complicated. Therefore, the team (Rawlings et al., 2004) developed a classification system of 
inhibitors based on sequence relationship and the relationship of protein fold on the inhibitory 
domain. An inhibitor domain is defined as the segment of the amino acid sequence containing 
a single reactive site after removal of any parts that are not directly involved in the inhibitor 
activity. Their searches of the amino acid sequence databases led to the retrieval of 2500 
sequences homologous to those of known peptidase inhibitors. On the basis of sequence 
homologies of their inhibitor domain proteinase inhibitors been classified into 48 families. As 
expected, the greatest numbers of inhibitors with a similar sequence were in the family serpin, 
I4, with over 500 sequences. In turn, families are divided into clans. The study of inhibitors of 
proliferation of living organisms found, only three families are known so far from Archaea, 
two of which (I4 (serpins) and I42 (chagasin)) are present in all three superkingdoms. I4 is the 
most widespread of all, being found even in viruses (Rawlings et al., 2004).  
3. The use of protease inhibitors in medicine 
The discovery, development, and registration of a pharmaceutical are an immensely 
expensive operation and represent a rather unique challenge. For every 9000 to 10,000 
compounds specifically synthesized or isolated as potential therapeutics, one (on average) 
will actually reach the market. Each successive stage in the process is more expensive, 
making it of great interest to identify as early as possible those agents that are likely not to 
go the entire distance, allowing a concentration of effort on the compounds that have the 
highest probability of reaching the market (Das & Suresh, 2008). 
Throughout most of history, humanity has used as medicines from natural sources, such as 
medicinal plants, by-products of animals and insects, etc. After isolation of these active 
substances and determine their molecular structure, drug manufacturing has become more 
ambitious. This is confirmed by the fact that all 250 of the main structures of existing drugs, 
as well as their prototypes, 60% were derived from natural sources or has a common 
molecular structure (Spainhour, 2005; Molinari, 2009). Only a small number have been 
developed and synthesized "from scratch" (Spainhour, 2005).  
So, natural products have been the single most productive source of leads for the 
development of drugs. Over a 100 new products are in clinical development, particularly as 
anti-cancer agents and anti-infection (Harvey, 2008). 
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Mainly drugs are protein-based categories namely, recombinant proteins and enzymes, 
monoclonal antibodies and their derivatives, and synthetic peptides (Das & Suresh, 2008). 
Although there are studies that propose to use protein inhibitors as drugs. One of the 
problems of using proteins as drugs of instability in the gastrointestinal tract (GIT), and 
intravenous administration response from the immune system (Das & Suresh, 2008).  
To protect the protein drugs from cleavage by enzymes in the GIT using of encapsulation or 
complexation with inhibitors. Some researchers propose to encapsulation with an inhibitor 
aprotinin (Larionova et al., 1999a). Aprotinin – basic pancreatic trypsin inhibitor, which 
inhibits trypsin and related proteolytic enzymes. By inhibiting kallikrein, aprotinin 
indirectly inhibits the formation of activated factor XII, a biochemical reaction normally 
amplified by inhibition of the contact system and of fibrinolysis by aprotinin. Aprotinin 
inhibits the initiation of both coagulation and fibrinolysis induced by the contact of blood 
with a foreign surface (Mannucci, 1998). Further studies have shown the effectivity 
aprotinin for suppressing viral replication rhinotracheitis and adenovirus in vitro 
(Larionova et al., 2000b).  
Russian researchers (Valuev et al., 2001) have proposed as a protection from destruction of 
proteins in the digestive tract ovomucoid inhibitor included in the hydrogel. In the hydrogel 
also included insulin. As a result, the mechanism of action, this involves the inhibition of 
proteolysis of insulin due to neutralizing proteolytic enzymes and increasing the rate of 
diffusion of insulin from the particles through the small intestine. Rapid diffusion provided 
by interaction of the carbohydrate bonds of the hydrogel and of the ovomucoid with of 
lectins intestinal mucosa. 
Inhibitors of serine proteinase can be used in the therapy of diseases associated with bowels 
surgery. Under intestinal resection, as well as ulcerative colitis, a high activity of proteolytic 
enzymes in the faeces are observed, which is highly undesirable (Bohe, 1987). Studies have 
shown that inhibitors of serine proteinases from potato significantly reduce the depression 
of the skin in the anogenital region in patients with intestinal resection, as well as healthy 
children, in which the activity of proteinases in the feces is physiologically increased 
(Ruseler-van Embden et al., 2004). 
Proteinase inhibitors (aprotinin, ilomastat) can be used in the treatment of acute and chronic 
damage to lung tissue (Anderson et al., 2009; Weinberger et al., 2011). Chronic lung disease 
due to interstitial fibrosis can be a consequence of acute lung injury and inflammation. The 
inflammatory response is mediated through the migration of inflammatory cells (neutrophil 
granulocyte et al), actions of proinflammatory cytokines, and the secretion of matrix-
degrading proteinases. The activation of circulating granulocytes was characterized by 
increased production of serine proteinases and reactive oxygen metabolites. After the initial 
inflammatory insult, successful healing of the lung may occur, or alternatively, dysregulated 
tissue repair can result in scarring and fibrosis. On the basis of recent insights into the 
mechanisms underlying acute lung injury and its long-term consequences, data suggest that 
proteinases may not only be involved in the breakdown and remodelling that occurs during 
the injury but may also cause the release of growth factors and cytokines known to influence 
growth and differentiation of target cells within the lung (Neumann et al., 1999; Winkler & 
Fowlkes, 2001). 
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The effectiveness of proteinase inhibitors as anti-oxidants has been investigated on a model 
venom-induced tissue damage in rats by Scorpion venom toxins (Fatani et al., 2006).As an 
antioxidant was used inhibitor aprotinin. Aprotinin alone significantly reduces the venom-
elicited increase in glucose-6-phosphate dehydrogenase and lactate dehydrogenase activities 
and the decrease in glutathione peroxidase levels. But the best results were obtained when 
the joint application of extract of Gingko biloba leaves and aprotinin (Fatani et al., 2006).  
As we see the role of proteinase inhibitors in the pathogenesis of disease is significant. In 
our view, it is important to note the significance of inhibitors in tumours processes. Various 
types of proteinases are implicated in the malignant progression of tumours and increase 
oxidative stress (Koblinski et al., 2000; Aoshiba al., 2001). To be fair, it is not always 
proteases have been associated with cancer progression (Lуpez-Otin & Matrisian, 2007).  
Nevertheless, proteinase inhibitors may therefore be useful as therapeutic agents in anti-
invasive and anti-metastatic treatment. Studies have shown that potato cysteine proteinase 
inhibitor PCPI 8.7 inhibited invasion B16 mouse melanoma cell by 21% and serine 
proteinase inhibitor reduced invasiveness by up to 24 % (Sever et al., 2005). Overexpression 
of cathepsin B excessively associated with adenocarcinoma of the esophagus and other 
cancers (Kos & Lah, 1998). 
Trypsin inhibitor from soybean BBI 3 can suppress the growth of cancer cells (Armstrong et 
al., 2000). Because of its inhibitory properties BBI3 can be used inside in the form of capsules 
and tablets, dispersible in the gut, not worrying about what will be split by proteases of the 
gastrointestinal tract. 
A very interesting example may be the use of Bowman-Birk Inhibitor (BBI) from soybeans in 
the treatment of multiple sclerosis. Proteases generated during inflammation are involved in 
the induction of tissue damage during inflammatory demyelination in the central nervous 
system. Both in vitro and ex vivo, BBI inhibited myelin basic protein-specific proliferation of 
lymph node cells. BBI reduced the activity of matrix metalloproteinase-2 and -9 in spleen 
cell supernatants and was detected in the central nervous system of treated rats.  
BBI suppresses experimental autoimmune encephalomyelitis, it can be administered orally, 
and it is safe and relatively inexpensive. It may have a therapeutic role in patients with MS 
(Gran et al., 2006). 
Bifunctional inhibitor of xylanase and aspartic proteases from extremophilic microorganism 
Bacillus sp. aspartic proteinase inhibits HIV-1 (Dash et al., 2001). 
The Bowman-Birk trypsin-chymotrypsin inhibitor (BBI) from soybean has been proposed as 
anticarcinogenic drugs. The BBI inhibited the growth of human colorectal adenocarcinoma 
HT29 cells in vitro (Clemente et al., 2005). 
The trypsin inhibitor from Peltophorum dubium seeds (PDTI), as well as soybean  
trypsin inhibitor (SBTI), both belonging to the Kunitz family, have lectin-like properties and 
trigger rat lymphoma cell apoptosis. It was shown that PDTI and SBTI induce human 
leukemia Jurkat cell death. Induction of apoptosis was confirmed by flow cytometry 
(Troncoso et al., 2009).  
In our research studies the cytotoxicity of trypsin inhibitor extract (Islamov & Fursov, 2007) 
from wheat seeds was evaluated by counting the cells at the time of harvest, with a 
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haemocytometr. Cytotoxicity in treated cultures was assessed by Relative increase in cell 
counts (Fellows & O’Donovan, 2007; Lorge et al., 2008). This study was made on L5178Y TK  
+/- clone 3.7.2c mouse lymphoma cells which were obtained from American Type Culture 
Collection. Cells were cultured in RPMI 1640 medium supplemented with 10% heat-
inactivated horse serum, 200 U/ml penicillin, 50 µg/ml streptomycin, 2.5 µg/ml 
amphotericin B, 200 µg/ml L-glutamine, 200 µg/ml sodium pyruvate and 500 µg/ml 
pluronic acid. Cell cultures were grown in a humidified atmosphere with 5% CO2 in air at 
37°C. Cells tested negative for mycoplasma contamination and were routinely passaged to 
maintain exponential growth. Three concentration of trypsin inhibitor substance was tested 
1/1000, 1/100, 1/10 (v/v). The exposure was 24-h and 0-h recovery. Utilizing exponentially 
proliferating cells, 96 V-bottomed wells were seeded at a concentration of 6×104 cells per 
well. Each concentration was performed in triplicate. At the end of treatment time 20 µl of 
cells from each concentration was mix with trypan blue 1:1 (v/v). An aliquot of the cell 
suspension was then transferred to a hemacytometer for cell counts. The cell counts were 
used to determine Relative increase in cell counts. Representative results for trypsin 
inhibitor extract are shown in Table 1. 
 
Concentration of trypsin inhibitors 
 (µg/ml) 
% Toxicity RICC* 
Negative control 0 
500 100% 
50 91% 
5 14% 
*Relative increase in cell counts 
Table 1. Cytotoxicity trypsin inhibitors from grain wheat 
Our studies have shown the cytotoxic effect of trypsin inhibitors. Similar results were 
obtained in cell culture H28 of malignant mesothelioma. When adding Bowman-Birk 
protease inhibitor from soybeans at concentrations of 200-400 μg/ml Inhibition of cell 
growth (Kashiwagi et al., 2011). Currently, research is continuing to explore mechanisms of 
toxicity. Apparently, this may be related to the processes of apoptosis (Troncoso et al., 2009). 
A completely different example of the serpin CrmA (cytokine response modifier A), which 
expresses Cowpox virus. The targets of CrmA are members of the caspase family of 
proteases that either initiate the extrinsic pathway of apoptosis (caspases 8 and 10) or trigger 
activation of the pro-inflammatory cytokines interleukin-1ǃ and interleukin-18 (caspase 1). 
CrmA has the typical fold of a cleaved serpin, even though it lacks the N-terminal half of the 
A helix, the entire D helix, and a portion of the E helix that are present in all other known 
serpins. Thus, the inhibitory proteins can be not only drugs. They may also viral 
countermeasures to host defenses against infection may contribute significantly to the 
pathology associated with poxvirus infections (Renatus et al., 2000). 
Such examples are very much (Polya, 2003). All this points to the crucial regulate the activity 
inhibitors of proteinase activity. In addition, the study of mechanisms of interaction enzyme 
with inhibitor can tell researchers how to develop new drugs - semi synthetic (including 
modified) and synthetic (non-protein). So, after some modification of the reactive site serpin, 
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they acquire the ability to block angiogenesis and induce tumor regression (Carrell, 1999). 
Successfully completed Phase 2 clinical trials engineered protein inhibitor of human 
neutrophil elastase (Dyax Corp. & Debiopharm). Human neutrophil elastase, an enzyme 
produced as part of the inflammatory response, is implicated in the loss of lung function in 
patients with cystic fibrosis and other clinical conditions. (Dyax Corp. & Debiopharm). The 
inhibitor of human neutrophil elastase is derived from the Kunitz-type domain of inter-ǂ-
inhibitor which is a natural inhibitor of human neutrophil elastase normally present in 
plasma (Grimbert et al., 2003).  
There is enough work, in which information about the protease inhibitors and their 
application (Wenzel & Tschesche, 1995; Polya, 2003).  
4. Inhibitors in agriculture 
Considering the basic properties of inhibitors - inhibition of enzyme activity, they have 
successfully used to control pests. It is known that plants are often damaged by many 
different pathogens - fungi, bacteria and viruses (Selitrennikoff, 2001; Franco et al., 2002). 
Also, insects and parasitic worms of plants are cause illness and death of plants frequently, 
causing great agricultural economic losses. However, during infection of plants by 
infectious agents, not all plants of one population or species ill. This is due to 
phytoimmunity - the ability to resist pathogens (Valueva & Mosolov, 2002; Mosolov & 
Valueva, 2008). Protective mechanisms were elaborated in the long process of co-existence 
of host and parasite. The major components of the existing protection mechanisms are 
substances of protein nature. These include enzymes - glucanase, chitinase and protease 
inhibitors and ǂ-amylase. For example, damage to tomato leaves (Licopersicon esculentum 
Mill.) by insects or microorganisms induce the synthesis of more than twenty different 
proteins, including inhibitors of serine, cysteine proteinases and aspartilnyh and ǂ-amylase 
(Valueva & Mosolov, 2002). 
Inhibitors of trypsin and chymotrypsin from soybeans, beans and potato to suppress 
proteinase from phytopathogenic fungus (Fusarium solani). Moreover, the inhibitors 
belonging to the family of Bowman-Birk inhibit the growth of hyphae and conidia 
germination of fungi Fusarium solani, F. culmorum and Botrytis cinerea, etc. (Loreti et al., 
2002). Along with trypsin and chymotrypsin inhibitors in plants and detected proteins that 
inhibit proteases of microorganisms. 
Quite interesting are bifunctional inhibitors. Bifunctional inhibitors - proteins that contain 
two active sites, interacting as one of the enzymes, eg trypsin/trypsin, and various enzymes 
- trypsin/chymotrypsin or proteinase/amylase (Sreerama et al., 1997; Valueva & Mosolov, 
2002; Mosolov & Valueva, 2008).  
Bifunctional (double-headed) inhibitors of proteases, traditionally, belong to the family 
Bowman-Birk inhibitors. Bifunctional inhibitors are assumed to have arisen by duplication of 
an ancestral single headed inhibitor gene and subsequently diverged into different classes and 
with a network of highly conserved disulfide bridges (Odani et al., 1983; Qi et al., 2005). 
However, interest bifunctional inhibitors active against both proteases and amylases (Table 2). 
The first three bifunctional inhibitor (BASI, WASI and RASI) show significant similarities in the 
structure and properties (Ohtsubo & Richardson, 1992; Franco et al., 2002; Nielsen et al., 2004).  
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Inhibitors 
Family or 
subfamily 
Source 
Molecular 
weight, 
kDa 
Isoelectric 
points 
Residue 
numbers 
Reference 
-amylase/subtilisin 
(BASI) 
I3A (Kunitz 
(plant) 
Hordeum 
vulgare L 
19,879 7,2 181 
(Nielsen et al., 
2004) 
-amylase/subtilisin 
(WASI) 
I3A (Kunitz 
(plant) 
Triticum 
aestivum 
L 
20,5 7,2 187 
(Mundy et al., 
1984) 
-amylase/subtilisin 
(RASI) 
I3A (Kunitz 
(plant) 
Orysa 
sativa L. 
21 9,05 189 
(Yamasaki et 
al., 2006) 
-
amylase/proteinase 
К (PKI3) 
- 
Triticum 
aestivum 
L 
19,6 > 7 180 
(Zemke et al., 
1991) 
-amylase/trypsin 
(BIAT) 
I6 (cereal) 
Triticum 
aestivum 
L 
14,0 10 - 
(Islamov & 
Fursov, 2007) 
-amylase/trypsin 
(RBI) 
I6 (cereal) 
Eleusine 
coracana 
Gaertneri 
13,3 10 122 
(Maskos et al., 
1996) 
Table 2. Bifunctional inhibitors of amylase/protease of cereals  
Thanks to the "dual" activity, the bifunctional inhibitor of amylase/proteinase appears to 
provide synergetic effect in protecting against pathogens. Bifunctional inhibitors of the 
subject of many articles and studies (Konarev et al., 1999; Franco et al., 2002; Birk, 2003; 
Salcedo et al., 2004; Pouvreau, 2004; Habib & Fazil, 2007). 
The essential role of inhibitors in plant protection from insects and other pests inspired the 
creation of transgenic plants. Transgenic plants with enhanced resistance to insects, 
containing the genes of proteinase inhibitors. Trypsin inhibitor gene (SrTI) of cowpea (Vigna 
unguiculata L.) was transferred into tobacco plants (Nicotiana tabacum L.). Plants content SrTI 
reached 1% of total soluble protein, the defeat of the tobacco cutworm larvae plants 
decreased by 50% (Valueva & Mosolov, 2002). Along with transgenic plants containing 
genes of serine protease inhibitors were obtained plants expressing genes of inhibitors of 
cysteine proteinases. Extracts of potato containing the gene of LS-1, effectively inhibited the 
activity of proteinases from the digestive tract Colorado potato beetle (Leptinotarsa 
decemlineata Say) (Mosolov & Valueva, 2008). 
Differential expression of the CaMV proteinase inhibitor obtained the transfer of the 
corresponding gene using Agrobacterium transformation into the genome of tobacco culture 
(Solanum nigrum) and alfalfa (Medicago sativa). Expression was studied by measuring mRNA 
levels in leaves of CaMV. It was also shown the accumulation of inhibitors in the vacuoles of 
Solanum nigrum to 125 mg per 1 g of tissue, tobacco, 75 mcg / g, alfalfa 20mkg / g (Valueva 
& Mosolov, 2002). In a similar way shape transgenic peas (Pisum sativum), which is 
introduced into a plant ǂ-amylase cDNA inhibitor I bean (Phaseolus vulgaris) and 
"substituted" under a strong promoter of phytohemagglutinin. As a result, the inhibitor 
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content increased to 3% of soluble protein, compared with the control (1%). Although I 
inhibitor inhibits ǂ-amylase man, his concentration was not sufficient to disrupt the 
digestive proces (Schroeder et al., 1995).   
Inhibitors of proteolytic enzymes may play an important role in plant protection not only 
from harmful insects, but also other pests: nematodes, the nematodes. Many nematodes are 
parasitic on plants and cause significant damage to agricultural production. In the gut of 
nematodes contains active cysteine and serine proteases, including chymotrypsin and 
kallikrein is similar. It is interesting that when infected with worms, among transcripts of 
tomato were found proteins related to the family of Kunitz inhibitor (SBTI) (Valueva & 
Mosolov, 2002; Schroeder et al., 1995).    
Expression of proteinase inhibitor chimera-II-CAT in tissues of potato tobacco prevailed 50 
times under the influence of 1% sugar (maltose, glucose and fructose) in the farmed 
environment. Adding mannitol to the nutrient medium in place of these sugars does not 
affect the synthesis inhibitor-II-CAT (Valueva &Mosolov, 2002). The resulting transgenic 
plants from cell cultures of tobacco leaves revealed sensitivity to a 3% sucrose, which results 
in increased synthesis inhibitor-II-CAT 3-fold (Mundy et al., 1986). In addition, a mechanical 
failure of one of the leaves of the plant stimulates the transcription of genes encoding 
proteinase inhibitors are not only damaged but also in intact tissues. Systemic induction of 
gene expression was also observed with wounds or infected tomatoes (Valueva & Mosolov, 
2002). Similar results, mostly on potatoes are presented in studies and reviews (Rolland et 
al., 2002). 
In the process of co-existence of plants and their vermins, every organism has developed a 
protection system, and ways to overcome this protection. Plants synthesize a large number 
of different inhibitors, which makes them not edible. In response, many vermin have 
developed a system of protection against these inhibitors. Especially, began to secrete 
enzymes are not susceptible to inhibition by inhibitors of the existing (Maarten & Jules, 
2011). For example, instead of trypsin, which is actively suppressed by inhibitors of trypsin 
and which are enriched with plants, insects began to synthesized chymotrypsin-like 
enzymes (Valueva & Mosolo, 2002). So, in future research the question of the co-evolution of 
insect proteases and plant inhibitors should be better approached from a systems level. 
Apart from the use of inhibitors in the creation of transgenic plants resistant to certain 
pathogens, they are also of interest as genetic markers to study diversity, evolution and 
plant breeding. In many Compositae plants shows monogenic control, while interline 
crosses, loci coding for many protein inhibitors, have demonstrated linked inheritance. For 
example, the cyclic inhibitor, with a mass of 1.5 kDa and trypsin inhibitor, three groups of 
sunflowers, which, according to the results of mating, gave the values of the recombination 
frequencies for different pairs of loci from 0.23 to 0.40 in F2. Small molecule inhibitors of the 
information on the TI better match the taxonomy of Asteridae, based on data for molecular 
markers than the classical (Lawrence & Koundal, 2002). 
A number of cereal caryopsis contains two clearly divided groups of inhibitors with a mass 
of 12 and 24 kDa. A comparative study of intraspecific polymorphism of these proteins and 
their components of different species showed that the evolution of the spectrum there is a 
complication of inhibitors and most complete range of typical soft hexaploid wheat 
(Schroeder et al., 1995).  
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In the works of A. Konarev (Konarev et al. 1999; Konarev et al., 2004) shows in detail the 
variability of inhibitors of trypsin-like proteinases in cereals due to resistance to various 
grain pests. So in wheat trypsin inhibitors are represented by several genetically 
independent systems of proteins controlled by the genome and B chromosomes 1D 
(endosperm), 3Dǃ (aleurone layer), 1DS and 3Aǃ (leaf). Trypsin inhibitors of rye are 
controlled chromosome 3R and barley 3H. The most complex structure of inhibitors was 
wheat leaves, with the genomic formula AABBDD. In general, it is the sum of the spectra of 
trypsin inhibitors from several tetraploid (T. turgidum) (ААВВ) and (Aegilops tauschii 
Coss.) (DD) (Konarev, 1986; Konarev et al., 2004).  
In addition to the trypsin inhibitors are very interesting inhibitors of chymotrypsin and 
subtilisin, which are the most heterogeneous structure and variability of all species of wheat 
and corn and barley, which are controlled by fifth chromosome, while the wheat and rye - I 
homoeologous group of chromosomes of different genomes. In diploid wheat, a number of 
species (T. timopheevii) identified the protein components capable of inhibiting both 
subtilisin and chymotrypsin, which are characterized by low variability (Konarev et al., 
2004). 
Investigation of the stability of different wheat varieties to pest insect (Rhyzopertha dominica 
F) showed some dependence on composition of trypsin inhibitors and chymotrypsin. 
Grades Kirghiz 16, Saratov 41 had low levels of trypsin inhibitors and demonstrated the 
instability to the pest insect. Whereas grade Kalayan Sona, Saba, Diamond, Aurora 44, 
Zernogardskaya 39 were resistant to grain pest insect. This is also confirmed by the fact that 
part of the digestive enzymes R. dominica F. are trypsin-like proteases. In addition, a variety 
Zernogardskaya 39 contained a number of specific inhibitors of ǂ-amylase insects (Konarev, 
1986; Konarev et al., 1999; Konarev, 2006). 
As we see the potential use of inhibitors in agriculture and in particular, to protect plants 
from pests wide. Such an approach to crop protection against loss of environmentally safer 
and economically more advantageous. Since there is no need to conduct expensive 
toxicological studies of new insecticides. The products of these plants are safe for humans 
and animals. And the use of transgenic technology will accelerate the development of new, 
resistant to insect pests, plant varieties. 
5. Conclusion 
Presented data from studies of protein inhibitors of serine proteases confirm their crucial 
role in the regulation of proteolytic enzymes. Examples of their use as drugs, crop protection 
agents, antioxidants, etc. are given in this chapter. No less interesting is the diversity of the 
whole family of inhibitory proteins - Serpin. Nevertheless, there are several obstacles to 
widespread use of inhibitors: 
1. Several inhibitors of serine proteases can cause allergies.  
2. Intravenous application of inhibitors is extremely difficult because of their antigenic 
properties.  
3. Increased production of one of the inhibitor in the plant is inefficient, since most 
vermins are able to quickly adapt to it.  
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At the same time, there are positive aspects for the development of research inhibitors. It 
should also be noted.  
1. Studying the mechanisms of interaction of natural protein inhibitors of enzymes 
provides an opportunity to develop approaches to the preparation of synthetic, small 
molecule inhibitors.  
2. The prevalence of proteinase inhibitors in all kingdom, from viruses to eukaryotes, and 
indicates their important role in the regulation of proteolysis.  
3. The use of two or more inhibitors at the same time to protect plants from pests, 
reducing the ability of pathogens to adapt. 
So, enzyme – inhibitor interactions are very important process into living organisms. To 
date, a variety of genetic and biochemical methods exist for studying enzyme - inhibitor 
interactions and identifying of such interactions. 
As mentioned earlier, of methods of the quantum chemistry, not only managed to learn in 
detail about HIV integrase, but also to develop an algorithm for obtaining drugs based on 
organic complexes of iodine. The next step is to study the inhibition of organic complexes of 
iodine with HIV proteinase. 
Quite promising direction is also in search of new plants, small inhibitors. Examples of the 
serpin showed that any protein can potentially be an inhibitor that expands the range of 
functional significance of the proteome. 
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